MedPath

CLINICAL TRIAL COMPARING ARNI WITH ACE INHIBITORS IN POST SURGICAL PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION BY CLINICAL AND ECHOCARDIOGRAPHIC STUDY

Phase 4
Conditions
Health Condition 1: I502- Systolic (congestive) heart failure
Registration Number
CTRI/2018/09/015847
Lead Sponsor
OT APPLICABLE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ALL POST CARDIAC SURGERY PATIENTS OF AGE ABOVE 18 YEARS WITH LEFT VENTRICULAR EJECTION FRACTION LESS THAN OR EQUAL TO 40 PERCENT ON CLINICAL AND ECHOCARDIOGRAPHIC EVALUATION WHO ARE READY TO GIVE INFORMED CONSENT.

Exclusion Criteria

1 PATIENTS WITH MULTISYSTEM DISEASE

2 PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY

DISEASE

3 PATIENTS WITH CHRONIC KIDNEY DISEASE WITH

DECREASED CREATININE CLEARANCE LESS THAN 30ML

4 PATIENTS WITH SERUM POTASSIUM GREATER THAN

5.5 MMOL PER LITRE

5 PATIENTS WITH BILATERAL RENAL ARTERY STENOSIS

6 PATIENTS WITH SYSTOLIC BLOOD PRESSURE LESS

THAN 90MMHG

7 PATIENTS WITH A KNOWN HOSTORY OF ANGIOEDEMA

8 PATIENTS WITH HISTORY OF HYPERSENSITIVITY TO

SACUBITRILVALSARTAN OR DRUGS OF SIMILAR

CHEMICAL CLASSES OR KNOWN INTOLERANCE OR

CONTRAINDICATIONS TO STUDY DRUGS OR DRUGS OF

SIMILAR CHEMICAL CLASSES INCLUDING ACE

INHIBITORS ARB OR NEP INHIBITORS

9 PATIENTS UNWILLING TO ENROLL FOR THE STUDY

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath